⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Jill McculleyMS PAC

Physician Assistant · Wilmington, NC 28403

NPI: 1407819964

Share:

41

🟠 Elevated

Risk Flags

High opioid rate vs specialty peers95th percentile opioid prescribingHigh long-acting opioid rate vs peersOpioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

7,440

Total Claims

$967K

Drug Cost

535

Beneficiaries

$1,808

Cost/Patient

Risk Score Breakdown 41/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+10
Opioid rate (national percentile)+10
Long-acting opioid rate+8
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 109,535 Physician Assistant providers

+529%

Opioid rate vs peers

57.8% vs 9.2% avg

+151%

Cost per patient vs peers

$1,808 vs $719 avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

Opioid prescribing rate is 529% above the average for Physician Assistant providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

57.8%

Opioid Rate

4,301

Opioid Claims

$492K

Opioid Cost

24.0%

Long-Acting Rate

This provider's opioid prescribing rate of 57.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 6,581 claims · $481K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Levorphanol Tartrate107$289K
Buprenorphine Hcl193$173K
Oxycodone Myristate117$83K
Tapentadol Hcl52$59K
Naloxegol Oxalate100$54K
Buprenorphine107$37K
Oxycodone Hcl/Acetaminophen869$24K
Hydrocodone Bitartrate28$18K
Oxycodone Hcl968$18K
Tapentadol Hcl29$18K
Linaclotide28$16K
Oxycodone Hcl25$15K
Hydrocodone/Acetaminophen629$15K
Lubiprostone45$13K
Naloxone Hcl132$11K

Prescribing Profile

46

Unique Drugs

41.0

Anomaly Score

Patient Profile

69

Avg Age

66%

Female

1.61

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About